No Deadlines – Private Funding Opportunities
The Private Funding Opportunities with foundations accepting applications on an ongoing basis, database table below is listed by disease and/or field in alphabetical order. Please type inside the search table below the disease, the specific grant name, name of agency or any other keywords to find more information about any biomedical research grants or educational grants available with no deadlines.
Return to the Calendar of Funding Opportunities here.
| Disease/Field | Funding Agency | Name of Grant / Description | Eligibility / Amount | Deadlines |
|---|---|---|---|---|
| Alzheimer’s Disease and Related Dementias | Alzheimer’s Drug Discovery Foundation (ADDF) | Diagnostics Accelerator: Peripheral Biomarkers Program is soliciting projects to develop biomarkers for Alzheimer’s disease and related dementias accessible from the periphery. | Award amounts will be based on stage and scope of research. | Accepting applications on a rolling basis. |
| Anesthesiology | Foundation for Anesthesia Education and Research | Transition to Independence Grants aim to support the transition of investigators from mentored training-focused support to independent (non-mentored) research support. | $75,000 1 year | Applications will be accepted on a rolling basis |
| Angelman Syndrome | Foundation for Angelman Syndrome Therapeutics (FAST) | Postdoctoral Fellowships – To increase the number of bright and creative scientists working on Angelman syndrome. Successful applicants for these grants will likely be working in established labs with secure overall funding, which have funding for supplies and any required animal handling costs. | $50,000.00 per year for two years for salary, fringe and consumable costs | Applications will be accepted on a rolling basis |
| Angelman Syndrome | Foundation for Angelman Syndrome Therapeutics (FAST) | FAST Grant-in-Aid – These are smaller, one-time awards to provide funds for needed equipment, reagents, or research costs to further promising projects on Angelman Syndrome. | Typical awards total approximately $10,000.00 but FAST will consider additional funding if warranted. | Applications will be accepted on a rolling basis |
| Angelman Syndrome | Foundation for Angelman Syndrome Therapeutics (FAST) | FAST Targeted Research to Advance a Cure (FAST TRAC) Awards – To stimulate the development of potential pharmacological therapeutics, biomarkers, and outcome measures for the treatment of Angelman Syndrome. Grants are given based on innovation, translational relevance, and significant potential to move through the translational pipeline towards treatment. Clinical trials are our highest priority, followed by preclinical research (i.e. rescue of animal models), and then translational research. | $150,000.00 per year for one or two years. | Applications will be accepted on a rolling basis |
| Ataxia-telangiectasia | A-T Children’s Project | Research Grants for basic science, translational and clinical research grants related to ataxia-telangiectasia. | $75,000 per year up to 2 years | Grants are reviewed on a rolling basis and awarded quickly compared to most other grant-giving organizations. In most cases, a grant decision will be made and communicated to the applicant within 90 days after the grant is submitted. |
| Autism Spectrum Disorders (ASD) | Simons Foundation Autism Research Initiative (SFARI) | The SFARI Supplement to Enhance Equity and Diversity (SEED) is a new program that provides supplements to existing grants for the recruitment of new lab members from American underrepresented minority groups at the postdoctoral level. | $100,000 per year for 3 years. | Applications will be accepted on a rolling basis |
| ASXL Congenital Syndromes | ASXL Rare Research endowment (AЯRE) | Basic Scientific and Clinical Research projects focused on advancing understanding of ASXL genes and improving the treatment and management of individuals with congenital ASXL syndromes. | Up to $100,000 for 1 or 2 years. | Proposals are accepted on a continual basis for subsequent review. Decisions will be made within six months of proposal submission. |
| Breast Cancer | Earlier.org – Friends For An Earlier Breast Cancer Test | Innovative Testing Research grant supports pilot research projects focused on improving the detection of early-stage breast cancer. | $50,000 (effective beginning with the 2025 grant cycle) over a 1-3 year period. | On a rolling basis, we accept applications for pilot projects |
| Cat Eye Syndrome | National Organization for Rare Disorders (NORD) | Cat Eye Syndrome – One (1) grant of up to $30,000 for scientific and/or clinical research studies related to Cat Eye Syndrome. | $30,000 | Ongoing. Priority will be given to proposals that are submitted by May 7, 2018 |
| Clinical Training | Mallinckrodt Pharmaceuticals | Clinical Training Program (CTP), through the education and clinical training of HCPs and/or conduct of clinically relevant independent research under a fellowship grant. | For CTP grant requests exceeding $100,000 in funding, the Company will pay 85% of the approved grant amount prior to the funding program initiation. | The Grants Review Committee meets regularly to review all submissions |
| Chemistry of Indoor Environments/Science | Alfred P. Sloan Foundation | Chemistry of Indoor Environments to grow a new field of scientific inquiry focused on understanding the fundamental chemistry taking place in indoor environments and how that chemistry is shaped by building attributes and human occupancy. | Grants of <$125K are approved only quarterly. | LOI is accepted throughout the year. |
| Childhood Arthritis | Childhood Arthritis & Rheumatology Research Alliance (CARRA) | CARRA-Arthritis Foundation Data Analysis Support Grant instructions | $10,000 | Applications accepted on a rolling basis |
| Childhood Brain Tumors | A Kids’ Brain Tumor Cure Foundation (aka The PLGA Foundation) | A Kids’ Brain Tumor Cure Foundation purpose is to act as a catalyst for researchers world-wide to turn their attention to the area of pediatric low grade glioma brain tumor research and to award research grants for the most promising programs and studies. | $100,000-$500,000 for 1-3 years | LOI is accepted throughout the year. |
| Colorectal Cancer | Colorectal Cancer Alliance | Project Cure CRC Early-Career Investigator Awards aim to attract early career faculty with original ideas into the field of colorectal cancer research, thereby recruiting and supporting the next generation of CRC research leaders. Awardees will be provided funding to accomplish innovative and original, preclinical, translational, and/or early clinical research projects. | Up to $100,000 per year for two years (up to $200,000 total) | On a rolling basis |
| Colorectal Cancer | Colorectal Cancer Alliance | Project Cure CRC Senior Investigator Awards will fund potentially transformative ideas that will accelerate the translation of new therapies and technologies. Proposals may include investigator-initiated clinical trials and do not require IRB approval at the proposal stage. Collaborations are highly encouraged. | Up to $1,000,000 per year for two years (up to $2,000,000 total) | On a rolling basis |
| Colorectal Cancer | Colorectal Cancer Alliance | Project Cure CRC Pilot Awards support investigators who propose potentially transformative ideas that do not have extensive preliminary data but articulate a clear hypothesis and translational goals. Resources for such “high-risk, high-reward” projects are important to establish proof-of-concept, which may then leverage additional funding through more traditional avenues. | Up to $100,000 per year for two years (up to $200,000 total) | On a rolling basis |
| Colorectal Cancer | Colorectal Cancer Alliance | Project Cure CRC The Team Science Award will support team science, including public-private partnerships, that will drive CRC research to curative science. Research proposals that accelerate new innovations from bench to bedside and address current unmet clinical needs will be prioritized. | Up to $2,000,000 per year for three years (up to $6,000,000 total) | On a rolling basis |
| Coronavirus Disease (COVID-19) | Patient-Centered Outcomes Research Institute (PCORI) | COVID-19-Related Enhancements to Existing PCORI-Funded Research Projects | $500,000 limit (direct and indirect costs)—higher amounts will be considered on a case-by-case basis, based on applicants’ justification of the proposed amount | On a rolling basis |
| Coronavirus Disease (COVID-19) | Patient-Centered Outcomes Research Institute (PCORI) | COVID-19-Related Enhancements to Existing PCORI-Funded Engagement Awards | Engagement Award Enhancements may not exceed $150,000 (direct and indirect costs) | On a rolling basis |
| Coronavirus Disease (COVID-19) | Patient-Centered Outcomes Research Institute (PCORI) | COVID-19-Related Enhancements to Existing PCORI-Funded Dissemination and Implementation Awards | $500,000 limit (direct and indirect costs) for Dissemination and Implementation Project Award Enhancements— higher amounts will be considered on a case-by-case basis, based on applicant’s justification of the proposed amount. | On a rolling basis |
| Coronavirus (COVID-19) | Wellcome Trust |UK Department for International Development (DFID) | Joint Initiative on Research in Epidemic Preparedness and Response to help low- and middle-income countries prepare for and tackle epidemics. | Up to £2 million. | There are no deadlines. Expressions of interest should be submitted as soon as possible. We may close this call to new applicants at any time. |
| Cough, Respiratory | Merck Company | Cough Investigator Studies Program (MISP) | Funds to be determined according to fair market value. | Accepting proposals on a rolling basis. Reviews will occur monthly in 2019. |
| Cystic Fibrosis | Cystic Fibrosis Foundation (CFF) | Therapeutics Development Award (TDA) | Funding for component I is $600,000 over no more than a three- (3-) year period while Component II is in the range of $3M-$5M over no more than a three- (3-) year period | Letter of Intent rolling. By October 31 of every year. |
| Cystic Fibrosis | Cystic Fibrosis Foundation (CFF) | Path to a Cure (PTAC) is the research program to support development of treatments for the underlying cause of the disease and, ultimately, a cure for every person with CF. T/td> | The level of awards given through the Path to a Cure Initiative are expected to be substantially higher than those through the CFF Therapeutic Development Award (TDA) program, potentially up to tens of millions of dollars. C | Both LOI and full submissions are accepted throughout the calendar year, although it is highly unlikely that submissions not received by October 31 will be funded in that calendar year. |
| Cystic Fibrosis | Cystic Fibrosis Foundation (CFF) | Student traineeships are offered to introduce students to research related to cystic fibrosis. | $2,000 | By December 31 of every year. |
| Data & Computational Research and Technology | Alfred P. Sloan Foundation | Data & Computational Research Grants to accelerate scientific discovery by helping researchers fully exploit the opportunities created by recent advances in our ability to collect, transmit, analyze, store, and manipulate data. | Foundation makes grants year-round, though major grants (>$250K) are approved only quarterly. | LOI is accepted throughout the year. |
| Eating Disorders | Davis Foundation | Hilda and Preston Davis Foundation Awards Program for Eating Disorders Research is to support innovative, clinically relevant research that seeks to understand the underlying biology of eating disorders, including anorexia nervosa and bulimia nervosa, leading to improved patient care. | $200,000 2-year | February 11, 2019 Initial proposal |
| Fanconi Anemia (FA) | Fanconi Anemia Research Fund, Inc. | Fanconi Anemia Research Fund (FARF) seeks to fund interdisciplinary and translational research efforts that will lead to rapid discovery and development of therapies or strategies that treat, control, or cure Fanconi anemia (FA). | $25,000 – $250,000 for 1-2 years | Rolling submission for letters of intent (LOI) for the RGA program. |
| Focused Ultrasound | Focused Ultrasound Surgery Foundation | Clinical Indication Track is geared primarily towards preclinical and first-in-human clinical studies. It is meant to fund research projects that target a specific clinical indication and that could lead the way to a new reimbursable clinical application for image-guided FUS within five to seven years. | $100,000 | Abstracts are accepted and reviewed on a rolling basis. Full proposal February 1, May 1, August 1, and November 1. |
| Focused Ultrasound | Focused Ultrasound Surgery Foundation | High-Risk Track is intended for early-stage, high-risk, proof-of-concept research that, if successful, could have a profound impact on the field of focused ultrasound and that could change the way many conditions are treated. | $100,000 | Abstracts are accepted and reviewed on a rolling basis. Full Proposal by invite: Feb. 1, May 1, Aug. 1 and Nov. 1. |
| Frontotemporal Degeneration | Association for Frontotemporal Degeneration (AFTD) | Accelerating DRUG DISCOVERY for Frontotemporal Degeneration Research investigating the pathologic mechanisms underlying frontotemporal degeneration (FTD) is advancing, creating new targets for drug discovery. | $100,000 – $150,000 per year. | LOIs are reviewed on a rolling basis and can be submitted at any time prior to the July deadline. |
| Health Equity | Robert Wood Johnson Foundation (RWJF) | The Robert Wood Johnson Foundation (RWJF) Pioneering Ideas: Exploring the Future to Build a Culture of Health Program seeks proposals that are primed to influence health equity in the future. | The average Pioneer grant in 2019 was $315,031 | Rolling deadlines for the submission of Letters of Inquiry |
| Health Professional Education and Career Development, Clinical Education in the underserved populations, and Graduate Medical Education Reform | Josiah Macy Jr. Foundation | Board Grants are selected three times each year at our board meetings. | Amount varies depending on the budget for 1-2 years. For assistance in preparing your application contact David Gillerman at the Development Office. | Letters of Inquiry are accepted at any time |
| Health Professional Education and Career Development, Clinical Education in the underserved populations, and Graduate Medical Education Reform | Josiah Macy Jr. Foundation | President’s Grants can be given at any time for grants aligned with our priority areas. | $35,000 for 1 year. For assistance in preparing your application contact David Gillerman at the Development Office. | Grant applications are accepted at any time. |
| Inflammatory Bowel Disease | Crohn’s & Colitis Foundation of America | IBD Ventures is a funding mechanism intended to accelerate the discovery and development of novel research-based products with the potential to alleviate suffering caused by inflammatory bowel disease (IBD). | $500,000 | Applications may be submitted at any time and will be reviewed on a rolling basis. |
| Inflammatory Bowel Disease | Crohn’s & Colitis Foundation of America | The Litwin IBD Pioneers Initiative supports innovative clinical and translational research projects with the potential to impact the treatment of IBD patients in the near future. | Not above $130,000 for 1 year | LOI ongoing except December 1-January 13 and May 1 – June 30. January 14 and July 1 online application. |
| Lyme Disease | Bay Area Lyme Foundation | Research Grant funds research and development of novel diagnostics and treatments for Lyme disease. | Funding amount to be determined | Grant proposals are accepted on a rolling basis year round |
| Lymphangiomatosis and Gorham’s Disease | Lymphatic Malformation Institute (LMI) | Lymphangiomatosis and Gorham’s Disease grant is to explore novel research ideas. The LMI only awards a maximum of 1 year’s funding at a time, and grants needing renewal/extension are subject to rigorous review prior to the approval of next round of funding. | The period of award and level of funding is unique to each funded project, and depends wholly on the scope and requirements of each approach | Grant proposals are accepted on a rolling basis year round |
| Malonic Aciduria | National Organization for Rare Disorders (NORD) | Malonic Aciduria – One (1) grant of up to $50,000 for scientific and/or clinical research studies related to Malonic Aciduria. | $50,000 | Ongoing. Priority will be given to proposals that are submitted by May 7, 2018 |
| Microbiome │Immunology │ Genomics │Structural Biology │Cellular Physiology│ Neuroscience | G. Harold and Leila Y. Mathers Foundation | Basic scientific research, with potential translational application, is central to this goal, and fundamental to our operating principles. | Require itemized budget justification, providing detailed costs of investigators’ salaries, laboratory supplies, equipment, etc. Indirect costs may not exceed 10%. Any equipment purchases should be itemized in the proposal. | Applications are approved on a quarterly basis. A response, in the form of approval, rejection, or request for additional information, may be expected within 90 days of the submission of the formal proposal. |
| Neuroblastoma, Brain Tumors and Sarcomas | Solving Kid’s Cancer | The TDI of SKC only supports clinical research. The organization specifically focuses on novel clinical studies for neuroblastoma, brain tumors and sarcomas. We may fund studies in which additional pediatric cancer types are included in the study protocol. | $50,000 to $600,000 | Proposals are accepted and reviewed throughout the year on a rolling basis. |
| Non-surgical sterilization product or technology | Found Animals Foundation, Inc. | Found Animals offers Michelson Grants for research in pursuit of a single-dose, permanent, nonsurgical sterilization product or technology for use in male and female dogs and cats. | $250,000 USD per year for up to three years | LOIs may be submitted at any time. All LOIs are reviewed within one month of submission. |
| Pain | The MAYDAY Fund | MAYDAY Fund’s current grant-making targets are projects to address the following needs: • Research Bench to Bedside • Pain Thermometer • Knowledge & Networks • Alternative Strategies & Therapies |
Funds unspecified | Ongoing. The Trustees meet 3 times per year to review letters |
| Post-Orgasmic Illness Syndrome | National Organization for Rare Disorders (NORD) | Post-Orgasmic Illness Syndrome for scientific and/or clinical research studies related to Post-Orgasmic Illness Syndrome (POIS). | One (1) grant of up to $31,000 | Ongoing. Priority will be given to proposals that are submitted by May 7, 2018 |
| Respiratory Care | American Association for Respiratory Care (AARC) | The primary purpose of the AARC Research Program is to sponsor research initiatives which can document the clinical and economic impact of respiratory therapists in the delivery of health care. | $1,000,000 | Research Plan Abstract to be submitted prior to a complete application. |
| Scholarly Communicationand Technology | Alfred P. Sloan Foundation | Scholarly Communication Grants to empower researchers by supporting the development and adoption of new resources for managing the increasingly diverse array of digital communication channels, enabling scientists to more effectively locate relevant research, network with other researchers, and disseminate their work to the scientific community and the public. | Foundation makes grants year-round, though major grants (>$250K) are approved only quarterly. | LOI is accepted throughout the year. |
| Spinal Cord Injury Research | Wings for Life Spinal Cord Research Foundation | The Wings for Life Accelerated Translational Program (ATP) has been specifically designed to be able to accommodate obstacles to efficient clinical translation. | Not specified | No deadlines for clinical proposals for the Accelerated Translational Program (ATP). |
| Spinal Muscular Atrophy | Cure SMA | Implement Newborn Screening for Spinal Muscular Atrophy program for activities that will enable states to pre-symptomatically identify and treat pediatric SMA patients through the implementation of newborn screening programs. | $100,000 for 1 year | Rolling submissions for funding are now being accepted. |
| Various Diseases | Mallinckrodt Pharmaceuticals | Investigator Initiated Research (IIR) program supports clinical/pre-clinical studies to improve the lives of our patients by providing support towards independent, unsolicited research focusing on disease areas that help advance the medical and scientific understanding of our marketed and investigational products. | Funding requests submitted will be assessed to ensure that they do not exceed local fair market value. | The Grants Review Committee meets regularly to review all submissions and awards funding based on medical or scientific merit, unmet medical need, study feasibility, and availability of funds. |
| Various Diseases | Mallinckrodt Pharmaceuticals | External Collaborative Research (ECR) supports clinical/pre-clinical studies to improve the lives of our patients by providing support towards independent, unsolicited research focusing on disease areas that help advance the medical and scientific understanding of our marketed and investigational products. | Funding requests submitted will be assessed to ensure that they do not exceed local fair market value. | The Grants Review Committee meets regularly to review all submissions and awards funding based on medical or scientific merit, unmet medical need, study feasibility, and availability of funds. |
| Various Diseases | Genentech | Scientific Project Support provides funding for general research, translational research, other research or development projects, and/or other initiatives of research organizations, labs, and academic institutions. | $100,000 | Genentech has a rolling review policy when evaluating funding requests for scientific project support. This allows qualified requestors the opportunity to apply anytime during year. |
| Various Diseases | Genentech | Fellowship Programs open to a broad audience that benefit patients, the scientific or medical community, and/or public health. | $100,000 | Genentech has a rolling review policy when evaluating funding requests for scientific project support. This allows qualified requestors the opportunity to apply anytime during year. |
| Various Diseases | Genzyme a Sanofi Company | Grants Focusing on Our Therapeutic Areas. Genzyme distributes grants that target efforts in our areas of disease and therapeutic focus: Multiple Sclerosis, Rare Genetic Diseases, Cardiovascular Disease and Thyroid Cancer. | Amount not specified | Applications are accepted any time all year round. |
| Various Pediatric Health Issues | Thrasher Research Fund | The purpose of the E.W. “Al” Thrasher Awards is to improve children’s health through medical research, with an emphasis on projects that have the potential to translate into clinically meaningful results within a few years. | $300,000. A doctoral-level degree is required. | Concept paper accepted on a rolling basis. |
| Various World Problems | Audacious Project | Audacious Project is a collaborative approach to funding ideas with the potential to create change at a thrilling scale.They are focused on helping to fund ambitious ideas that tackle world problems. | The budgetary request may not be more than five times the annual operating budget. | Reviewing submissions on a rolling basis all year; over time, we may contact a small number of survey responders to submit an application. |
| X syndrome | FRAXA Research Foundation | Fraxa Clinical Trial Grants Highest priority is given to clinical trials of potentially disease-modifying therapeutics which have previously been validated in fragile X animal models. | MD and/or PhD/ Flexible in amount and duration. | Applications may be submitted at any time, but a Letter of Intent (LOI) is essential; initial inquiries should be directed to Dr. Michael Tranfaglia at mtranfaglia@fraxa.org. |